Daily Evolution of Insulin Sensitivity Variability with Respect to Diagnosis in the Critically Ill by Ferenci, Tamás et al.
Daily Evolution of Insulin Sensitivity Variability with
Respect to Diagnosis in the Critically Ill
Tama´s Ferenci1, Bala´zs Benyo´1, Levente Kova´cs1*, Liam Fisk2, Geoffrey M. Shaw3, J. Geoffrey Chase2
1Department of Control Engineering and Information Technology, Faculty of Electrical Engineering and Informatics, Budapest University of Technology and Economics,
Budapest, Hungary, 2Department of Mechanical Engineering, Centre for Bio-Engineering, University of Canterbury, Christchurch, New Zealand, 3Department of Intensive
Care, Christchurch Hospital, Christchurch School of Medicine, University of Otago, Christchurch, New Zealand
Abstract
Introduction: This study examines the likelihood and evolution of overall and hypoglycemia-inducing variability of insulin
sensitivity in ICU patients based on diagnosis and day of stay.
Materials and Methods: An analysis of model-based insulin sensitivity for n~390 patients in a medical ICU (Christchurch,
New Zealand). Two metrics are defined to measure the variability of a patient’s insulin sensitivity relative to predictions of a
stochastic model created from the same data for all patients over all days of stay. The first selectively captures large
increases related to the risk of hypoglycemia. The second captures overall variability. Distributions of per-patient variability
scores were evaluated over different ICU days of stay and for different diagnosis groups based on APACHE III: operative and
non-operative cardiac, gastric, all other. Linear and generalized linear mixed effects models assess the statistical significance
of differences between groups and over days.
Results: Variability defined by the two metrics was not substantially different. Variability was highest on day 1, and
decreased over time (pv0:0001) in every diagnosis group. There were significant differences between some diagnosis
groups: non-operative gastric patients were the least variable, while cardiac (operative and non-operative) patients
exhibited the highest variability.
Conclusions: This study characterizes the variability and evolution of insulin sensitivity in critically ill patients, and may help
inform the clinical management of metabolic dysfunction in critical care.
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Introduction
Stress induced hyperglycemia is a significant issue in critical
care, affecting up to 30–50% of patients and increasing morbidity
and mortality [1,2]. Controlling glycemia has proved difficult due
to the associated risk of hypoglycemia when highly dynamic
patients are treated with exogenous insulin [3]. Both extremes, as
well as glycemic variability, have been independently linked to
increased morbidity and mortality [4–6], creating a difficult
clinical problem.
More specifically, inter- and intra- patient metabolic variability
drive outcome glycemic variability and hypoglycemic risk [7]
making good control difficult. In particular, sudden and large rises
in insulin sensitivity can result in a hypoglycemic event when
exogenous insulin is given over a typical 3–4 hour measurement
interval. It is critical to determine the size and likelihood of these
intra-patient variations, to enable a more complete understanding
of the inherent risks in glycemic control.
Very few studies have examined time-varying evolution of
insulin sensitivity and its variability in the critically ill. Langouche
et al noted [8] that insulin sensitivity rose between days 1 and 5
over their large cohorts, but provided no daily or diagnostic
specific evolution. Lin et al showed [9] that hour to hour changes
for a clinically validated model-based insulin sensitivity metric
could be quite large as a function of current insulin sensitivity level
for a medical Intensive Care Unit (ICU) cohort that covered all
diagnostic categories and days of ICU stay. However, no studies to
date have explicitly described the evolution of intra-patient insulin
sensitivity and its variability on a daily basis, or for different
diagnostic categories.
Such information would provide insight into the risk of
hypoglycemia by diagnostic category and day of ICU stay.
Additionally, insight into the likelihood of glycemic variability
resulting from greater or lesser intra-patient variability of insulin
sensitivity could be attained. This research presents a first rigorous
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Table 1. Demographic data of patients.
Group Day 1 Day 2
n Age Sex n Age Sex
NOpC 28 59.5 (61.5)+16.5 (24) 35.7 18 58.4 (59.5)+16.1 (19) 38.9
OpC 35 72.9 (73)+7.12 (10.8) 22.9 21 72.9 (73)+6.54 (10) 23.8
NOpG 16 64.3 (67)+12.8 (15) 25 13 64.4 (71)+14.2 (18.5) 23.1
OpG 42 67.9 (72)+12.4 (13) 35.7 29 69.9 (72)+10.8 (11.3) 27.6
NOpO 119 54.7 (59)+18 (27) 46.2 101 54.5 (59)+18 (28) 42.6
OpO 21 50.8 (56)+19.2 (31) 38.1 16 54.9 (57.5)+18.5 (31) 43.8
Group Day 3 Day 4+
n Age Sex n Age Sex
NOpC 11 64.2 (63)+10.6 (16.3) 18.2 11 64.2 (63)+10.6 (16.3) 18.2
OpC 18 73.2 (73.5)+6.46 (9) 27.8 18 73.2 (73.5)+6.46 (9) 27.8
NOpG 13 64.4 (71)+14.2 (18.5) 23.1 13 64.4 (71)+14.2 (18.5) 23.1
OpG 23 69.2 (71)+9.46 (11.5) 26.1 23 69.2 (71)+9.46 (11.5) 26.1
NOpO 88 54.2 (58)+17.9 (26.5) 45.5 88 54.2 (58)+17.9 (26.5) 45.5
OpO 15 54.7 (57)+19.1 (33.5) 40 15 54.7 (57)+19.1 (33.5) 40
The distribution (according to length-of-stay and diagnosis group) and the most important demographic indicators of the patients. Data are shown in an n, age,
percentage of females format, with age statistics arranged in Mean (Median)+ SD (IQR) manner. Columns indicate minimum (and not exact) length-of stay, so the same
patient may appear in several cells.
doi:10.1371/journal.pone.0057119.t001
Figure 1. SI variability and its metrics. Illustration of the evolution of SI for a given patient (FT5002). Background colors represent the
cumulative distribution function of the prediction for SI nz1ð Þ based on SI nð Þ using the whole cohort; its 25th, 50th (i.e. median) and 75th percentile
is explicitly shown. Lower part of the Figure highlights the calculation of the two metrics using Hour #102 (Day #4.25, marked on the upper part) as
an example.
doi:10.1371/journal.pone.0057119.g001
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statistical analysis of inter- and intra- patient insulin sensitivity
variability as a function of diagnostic category and day of stay.
Materials and Methods
Ethics statement
The Upper South Regional Ethics Committee, New Zealand,
granted ethics approval for the audit, analysis, and publication of
these data. Data collection is described in detail in [10].
Patient data
Clinical data from n~390 patients (47,836 hours) in the
SPRINT medical ICU cohort [10] are used to identify hourly,
model-based insulin sensitivity (SI ) values (SI nð Þ). SPRINT is a
model-based, clinically validated tight glycemic control (TGC)
protocol that provides explicit control for both nutrition intake and
insulin input [10].
Hour-to-hour changes are evaluated for the cohort over all days
of ICU stay using a stochastic model [9] that provides kernel
density estimation-based distributions of SI nz1ð Þ values for each
current SI nð Þ value using all 47,836 data points. Table 1 shows
the patient demographic details, including diagnostic categories.
These were created based on the APACHE III codes, and consist
of operative and non-operative groups for cardiac, gastric and all
other patients (with abbreviations OpC, NOpC, OpG, NOpG,
OpO and NOpO, respectively). For the daily statistics, only
patients who had at least 24 hours of glycemic control and ICU
stay were used.
Variability metrics
Actual SI nz1ð Þ values for each day of ICU stay and each
diagnostic category (cardiac, gastric, all other, both operative and
non-operative in all three types) are compared to the distributions
provided by the stochastic model of Lin et al [9] that covers all
diagnostic categories and all days of ICU stay. The results thus
show the relative and absolute evolution of SI variability
(SI nð Þ?SI nz1ð Þ) for a given diagnostic category over time,
relative to all patients and days of stay, which should highlight
times or diagnostic groups with greater or lesser than average risk.
The percentile of the actual SI nz1ð Þ values on their predicted
distribution will be illustrated with histograms. If the prediction is
perfect (that is, the distribution of actual values is identical to the
predicted distribution), every 10% wide interval of the histogram
contains 10% of the measurements. This ideal case therefore
corresponds to a flat distribution. Kurtic distributions are seen
when the actual values were more concentrated at the median
than the predicted distribution, suggesting confidence bands could
have been tightened. In contrast, U-shaped distributions indicate
cases where confidence bands should be widened due to increased
variability.
Two metrics are used to assess variability for each patient over a
given day, and results are aggregated by diagnostic category. First,
a quadratic metric is defined as the average of squared deviations
of the percentile of the actual SI nz1ð Þ value on its predicted
distribution (from the overall cohort model) from the ideal 50th
percentile. This value increases the more variable a given patient.
The quadratic metric thus measures overall intra-patient variabil-
ity.
Second, a one-sided threshold metric counts the number of
SI nz1ð Þ values for a given patient that exceed the 90th percentile
of SI nz1ð Þ in the whole-cohort model of Lin et al [9]. This
metric thus counts the number of large positive changes in
SI nz1ð Þ that would induce large drops in glucose level on dosing
exogenous insulin based on the SI nð Þ value. A value greater than
10% for a given patient, day or diagnostic category indicates a
greater risk for these changes compared to the overall cohort on all
days of ICU stay. This metric thus specifically assesses hypogly-
cemic risk due to intra-patient variability in insulin sensitivity and
its daily evolution.
Hence, these two metrics measure overall variability and
hypoglycemic risk from variability. Clinically, the quadratic
measure is one of risk to glycemic control performance and
outcome arising due to variability in insulin sensitivity, and the
one-sided threshold assesses risk to patient safety in glycemic
control.
These metrics are illustrated on Figure 1, which shows the
evolution of the insulin sensitivity of a 67 years old male patient
(FT5002) with septic shock principal diagnosis (all other, non-
operative category) through 162 hours. Each patient has such a
trajectory. For every hour, the distribution of SI nz1ð Þ was
predicted based on SI nð Þ using the model of Lin et al [9], which is
illustrated with the underlying colormap representing the cumu-
lative distribution function of the predicted distribution. 50th
percentile (i.e. median) of this predicted distribution of SI nz1ð Þ is
explicitly shown. The Figure also illustrates how these metrics are
calculated, showing the predicted distribution and the actual SI
for a given hour.
Analysis of variability
An overall variability score can be calculated for a given
diagnosis group by averaging the overall variability scores for
patients belonging to that group. However, if the individual length
of stay differs, simple arithmetic averaging would assign unequal
weights for each patient’s measurements. To avoid the problems
associated with unequal weighting due to patient discharge, only
series of equal length were averaged. In particular, results and
analysis were divided by the first 24 hours (‘‘day 1’’), second
24 hours (‘‘day 2’’), third 24 hours (‘‘day 3’’), and remaining time
in ICU (‘‘day 4+’’). Thus only complete 24 hour intervals were
used (except for day 4+, of course) to avoid bias.
Per-patient average penalty score distributions by diagnosis
group each day are shown using violin plots [11]. Violin plots bear
similarities to boxplots, but use kernel density estimation to directly
convey information on the shape of the distribution for more
accurate comparison.
Statistical methods
To have an overall impression on the effect of the time spent in
ICU on the SI variability, a LOWESS estimator [12] was plotted
for the scatterplot of quadratic metric and time spent (in minutes)
per diagnosis group on Figure 2. It is immediately obvious that
time has a complex effect on SI variability, which exhibits a
biphasic behaviour in most of the cases. This might be worthy of
pursuit, despite the fact that the estimation at long length of stays is
unreliable due to relatively lower sample size.
However, now we will confine our attention to investigate the
early, seemingly mostly linear response of the first few days. (To
Figure 2. Evolution of quadratic SI variability per diagnosis group. LOWESS estimators for the scatterplot between minute-precision length
of stay and quadratic metric of SI variability, segregated according to diagnosis group. Dashed vertical lines indicate the end of the first four days.
doi:10.1371/journal.pone.0057119.g002
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illustrate this, the first four day is marked on Figure 2.) We
restricted the database to observations having Timev 8 000 min-
utes (i.e. the first 5.5 days of stay) for the estimation of the
forthcoming models, hence limiting it to the ‘‘linearity region’’ of
the SI variability vs. time function, as evidenced by Figure 2. The
linear functional form is also more tractable and easier to estimate.
To account for the grouping of the data, linear mixed-effects
modelling was used to find significant differences in SI variability
metrics between diagnosis groups and/or days [13,14]. The
(longitudinal) data were arranged in a two-way classification, with
time a within-subject factor and diagnosis group considered a
between-subject factor. In our model, the fixed effects were the
Time (time spent in ICU in minutes as a continuous variable) and
the Diagnosis (as a nominal factor with 6 levels) without intercept
(‘‘cell means coding’’). Minute-precision length-of-stay (Time) was
used for measuring time to make the estimation of the mixed-
effects model possible. The random effect was added with per-
patient grouping, with both random intercept and random slope
permitted with respect to time, both of which was deemed
necessary with LR-test (pv0:001 for both quadratic and one-sided
penalty) [15]. The inclusion of an AR(1) autocorrelation of the
within-subject errors was not found to be necessary for the
quadratic penalty (p~0:9961) [15]. The fixed effects interaction
terms between Time and Diagnosis were found to be insignificant
(p~0:8227 for quadratic penalty, p~0:2077 for one-sided
penalty) showing that that the slope with respesct to the time
spent in ICU does not depend on the diagnosis group, and were
thus eliminated. (Effect of Diagnosis was significant (pv0:0001 for
both penalty), so the intercept does depend on the diagnosis
group.) The resulting statistical model for the quadratic penalty of
SI variability was therefore the following:
Variabilityi,j~ b0,NOpC
:Classi,NOpCzb0,NOpG





z b1zb1,ið Þ:Timei,jzei,j ,
ð1Þ
where i identifies the patient, j identifies the measurement (i.e.
Timei,j is the time of the jth measurement on patient i), Classi,C is
the indicator variable for Class C (i.e. takes the value of 1 if patient
i is in class C, 0 otherwise). For the one-sided threshold penalty –
as the response is essentially binary – generalized linear mixed
effects (GLME) modeling [16] was used instead of the traditional
linear mixed effects (LME) modeling. The link function was
chosen to be logistic, and the distribution family was binomial. For
the quadratic penalty, LME modeling was used, but the penalty
score was (monotonically) logit-transformed beforehand to map
the skewed distribution on 0,0:25½  to an approximately normal
one on the real line [15]. This sacrifies the interpretability of the
coefficients for the correct specification of the model, but the
former was of little concern for us, as we will not use the numerical
values of the coefficients for further analysis. Linearity for the
transformed data was still feasible.
The coefficients are denoted with b for the fixed, and with b for
the random effects. The fixed effects coefficient of Time
characterizes – for the whole population – how variability changes
over time, with positive value implying increasing variability,
negative implying decreasing variability, and the absolute value
showing the size of this effect. The fixed effects coefficients of
diagnosis groups show the estimated variability of a patient in the
given diagnosis group when admitted to the ICU.
Restricted maximum likelihood (REML) was used for the
estimation of LME models and Laplace-approximation for
GLME. Residual variance was rather high in both cases,
indicating that the models were only able to capture a small part
of the variation – but this is to be expected, given that we use no
information other than time spent in ICU and diagnosis group.
After performing ANOVA to assess the significance of main
effects, post-hoc testing on significant effects was carried out using
Tukey’s Honestly Significant Differences (HSD) method [17],
providing the correction that takes the multiple comparisons
situation into account.
Data processing
Data processing was done using Mathworks Matlab (version
2009a). Statistical analysis was performed under the R statistical
program package [18], version 2.15.1 with nlme package for LME
modeling [19] and lme4 package for GLME modeling [20].
Results
Figure 3 shows the distribution of the percentile of actual
SI nz1ð Þ on its predicted distribution for different days and
diagnosis groups. Figure 4 shows the violin plot of the distributions
of per-patient overall variability metrics in different diagnosis
groups, segregated according to ICU day and diagnosis group.
Parameters of the fitted GLME model (for one-sided threshold
penalty) and LME model (for quadratic penalty) are shown in
Table 2.
The distributions in Figure 3 suggest poor coverage of the
whole-cohort model on day 1, almost ubiquitously across diagnosis
groups. On day 2, every diagnosis group ‘‘flattens’’, except for
Operative - Cardiac. On day 3, the predictions are acceptable in
every diagnosis group in that the actual distribution of SI nz1ð Þ
largely matches the whole cohort-predicted distribution. Finally,
on day 4 and onwards the coverage is very over-conservative in the
Operative - All other category.
Figure 4 (top row) suggests that one-sided threshold penalties
exhibit much larger, typically positively-skewed variations. There
is a slight trend in the central tendency, as median variability in
this metric appears to decrease as time increases. A trend towards
reduced spread in this (one-sided) variability over time is more
pronounced, indicating decreasing risk of hypoglycemia over time
when all else is equal.
In contrast, quadratic penalties are much more centrally
concentrated, and have a smaller coefficient of variation. The
continuous lowering of variability over time in every group is also
seen, but a reduction in spread is not as pronounced. The two
metrics are consistent in assigning ‘‘higher’’ and ‘‘lower’’
variabilities similarly over time and diagnostic group, albeit on
different scales.
As can be seen from Table 2, time trend was significant
(pv0:0001) with a coefficient of {0:1234/day for the one-sided
threshold penalty, and {0:1810/day for the (transformed)
quadratic penalty, indicating the decreasing variability over time
in both cases. These results also imply a decreasing risk of
hypoglycemia inducing variability in insulin sensitivity over time,
matching trends in Figure 4.
Figure 3. Distribution of predictions according to diagnosis and day of stay. Histograms of the percentile of actual SI nz1ð Þ values on their
predicted distribution grouped according to day (rows) and diagnosis group (columns). Dashed line indicates the ideal (uniform) case of perfect
prediction. The number of hourly measurements which was used to construct the histogram is shown in the title.
doi:10.1371/journal.pone.0057119.g003
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Post-hoc testing for diagnosis groups also revealed significant
differences. Using Tukey’s HSD method (see Table 3), Non-
operative - Cardiac group had significantly (p~0:0175) higher
variability than Non-operative - Gastric for the one-sided
threshold penalty. Non-operative - All other category also
exhibited marginally significantly (p~0:0832) lower SI variability
than Non-operative - Cardiac patients. The Operative - Cardiac
exhibited significantly (p~0:0444) higher variability than Non-
operative Gastric for the (transformed) quadratic penalty. These
results suggest that the Non-operative - Gastric group is amongst
the least variable groups, while the Cardiac groups exhibit the
highest variability irrespective of day. These results are consistent
with Figure 4, though it is worth noting that cardiac patients
‘‘change place’’ from day 1 to day 2 irrespective of penalty: Non-
operative - Cardiac patients are more variable than Operative -
Cardiac group on day 1, but this order is reversed from day 2
onwards.
Discussion
Clinically, those results indicate a decreasing likelihood of
hypoglycemia induced by large rises (variations) in insulin
sensitivity over short measurement and intervention intervals as
days of ICU stay increase based on the one-sided threshold results.
The overall risk of increased variability of both forms (one-sided
and quadratic metrics) by diagnostic category is highest for
Cardiac patient groups.
This latter observation is matching the increased hypoglycemia
observed in glycemic control studies in these cohorts (e.g. [21]).
The highest variability on day 1 is consistent with the increased
hypoglycemia and range observed in the first 24 hours in the study
by Bagshaw et al [4], which was associated with increased risk of
death. The overall higher variability (quadratic measure) on day 1
in all groups is also reflective of increased hypoglycemia and
variability reported in most glycemic control studies irrespective of
cohort [3,4].
The major strength of the present study is that it also provides a
rigorous statistical framework, which makes the quantification of
these effects possible. It is, however, limited in some sense because
it is inherently linked to the SPRINT protocol (as it interprets
variability as the deviation of the actual SI from its prediction
provided by the particular algorithm in that protocol).
The physiological causes of this variability have links to the
counter-regulatory and oxidative stress responses, and inflamma-
tory acute immune response typically seen in hyperglycemic
critically ill patients. That the variability declines over days 1–4 as
the acute phase passes also matches expectations and physiological
observations. Drug therapies, such as glucocorticoid or inotrope
use [22] among others, may also be implicated as a causative
factor. However, the high level of patient-specificity observed
within any group makes determining specific causes or magnitude
of effect difficult.
For glycemic control, high levels of variability combined with
infrequent BG measurement are a major disincentive to higher
insulin doses and/or low glycemic targets. The only study to
reduce both mortality and hypoglycemia [10] was notable in
modulating both insulin and nutrition inputs to achieve good
control with lesser insulin and thus reduce hypoglycemic risk.
Hence, either higher targets [23] and/or adding nutritional intake
into consideration in providing glycemic control [24] must be
considered for at least some diagnostic groups (e.g Cardiac
patients) and days of ICU stay (day 1) based on these results.
Table 3. Significance of the effect of diagnosis group with




Estimate p Estimate p
OpC - NOpC 20.3285 0.4188 0.0606 0.9992
NOpG - NOpC 20.7724 0.0172 20.5451 0.1505
OpG - NOpC 20.2984 0.5130 20.1889 0.8637
NOpO - NOpC 20.4096 0.0835 20.2317 0.6190
OpO - NOpC 20.5104 0.1438 20.3434 0.5038
NOpG - OpC 20.4440 0.3607 20.6057 0.0444
OpG - OpC 0.0300 1.0000 20.2495 0.4946
NOpO - OpC 20.0811 0.9890 20.2923 0.1525
OpO - OpC 20.1819 0.9335 20.4040 0.2077
OpG - NOpG 0.4740 0.2765 0.3563 0.5179
NOpO - NOpG 0.3628 0.5024 0.3135 0.5799
OpO - NOpG 0.2621 0.9034 0.2017 0.9539
NOpO - OpG 20.1112 0.9503 20.0428 0.9992
OpO - OpG 20.2120 0.8732 20.1545 0.9518
OpO - NOpO 20.1008 0.9919 20.1117 0.9817
Estimates of differences and the p-values for the test of their significance (using
Tukey-HSD post hoc testing for the multiple comparisons situation) for the
pairwise comparison of diagnostic categories.
doi:10.1371/journal.pone.0057119.t003
Table 2. Fixed effect coefficients of the fitted models for the






Non-operative - Cardiac 21.5807 20.5033
Operative - Cardiac 21.9092 20.4427
Non-operative - Gastric 22.3532 21.048
Operative - Gastric 21.8791 20.6922
Non-operative - All other 21.9903 20.7350
Operative - All other 22.0911 20.8467
Time (per minute) 20.00008571 20.0001257
Time (per day) 20.1234224 20.1810
pv0:0001 pv0:0001
Summary of the estimated fixed effect coefficients of the LME model for (logit-
transformed) quadratic penalty and the GLME model for the one-sided
threshold penalty, and the p-value for the test of significance for Time. The
coefficient of Time is given both per minute and per day (24:60~1440 times
the former).
doi:10.1371/journal.pone.0057119.t002
Figure 4. Distribution of per-patient variability scores according to diagnosis and day of stay. Violin plots of per-patient overall
variability scores segregated according to day and diagnosis group. Upper row shows one-sided threshold penalty metric, while lower row shows the
quadratic penalty metric. Thick vertical lines indicate the interquartile range, the crossing horizontal line is at the median. Dots indicate the mean.
doi:10.1371/journal.pone.0057119.g004
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Conclusions
Inter-patient variability in insulin sensitivity peaks on day 1
across diagnostic groups and metrics. Operative - All other
patients are more predictable after day 4 than an all patients and
days of stay model accounted for, shown by conservative coverage.
The distribution of overall intra-patient variability assessed per-
patient and the mixed-effects model shows there are distinctive
differences between diagnosis groups, irrespective of the time spent
in the ICU. In particular, the Non-operative - Gastric group
exhibits the smallest variability, while Cardiac groups are amongst
the most variable. Clinically, these results show decreasing risk of
hypoglycemia as length of stay increases, as well as some reduction
in glycemic variability when all else is equal. The overall results
can be used to guide the design and implementation of glycemic
management specific to diagnosis group and ICU day of stay to
improve control and reduce risk.
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